NSPC-ES:对中枢神经系统疾病的机制和功能影响
Yu Si1,2, Muhammad Abid Hayat1,2, Jiabo Hu1,2,3
1Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang 212013, People's Republic of China.
Biomedical materials (Bristol, England)
|June 25, 2024
概括
神经干细胞衍生的细胞外分泌物 (NSPCs-ES) 为中枢神经系统 (CNS) 疾病提供了有前途的替代疗法. 这些分泌物支持受损的神经元并增强功能恢复,基因编辑进一步提高了它们的有效性.
科学领域:
- 神经科学是一个神经科学.
- 再生医学是一种再生医学.
- 细胞生物学 细胞生物学
背景情况:
- 中枢神经系统 (CNS) 损伤具有严重的后果,治疗选择有限.
- 神经干细胞移植是一种成熟的神经元替代疗法.
- 来自神经干细胞 (NSPCs-ES) 的细胞外分泌物成为一种新的治疗方法.
研究的目的:
- 审查NSPCs-ES对中枢神经系统损伤的治疗潜力.
- 总结了NSPCs-ES疗效背后的机制.
- 讨论修改NSPCs-ES以改善治疗结果的进展.
主要方法:
- 在各种中枢神经系统损伤模型中研究NSPCs-ES的临床前研究.
- 对NSPCs-ES的细胞和分子影响的分析.
- 对NSPCs-ES应用的基因编辑和细胞工程技术的审查.
主要成果:
- NSPCs-ES在维持细胞结构和减少神经元中细胞亡方面表现出有效性.
- NSPC-ES 具有抗炎功能,并调节信号通路.
- 在临床前模型中,NSPCs-ES可以改善记忆和运动功能.
- 基因编辑增强了NSPCs-ES的治疗疗效.
结论:
- 在中枢神经系统疾病中,NSPC-ES代表了一种有前途的无细胞治疗策略.
- 这些分泌物具有神经保护和再生作用.
- 未来的研究和工程NSPC-ES的应用具有治疗中枢神经系统疾病的巨大潜力.
相关概念视频
Disorders of the Nervous Tissue
1.1K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.1K
Parkinson's Disease: Overview
524
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
524
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Neurochemical Transmission: Sites of Drug Action
2.2K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.2K
The Blood-brain Barrier
47.2K
Overview
47.2K
Neurotransmitters
866
Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
866


